Matt Hancock’s tell-all interview on Steven Bartlett’s Diary of a CEO podcast has been labelled ‘nauseating drivel’.
The former Health Secretary met with the Dragon’s Den star for an interview that lasted almost two hours.
In the chat, Hancock defended his now-very-public kiss with aide Gina Coladangelo, saying it was not casual sex but that he ‘fell in love’.
The tense clip from the podcast saw the MP repeatedly ask Bartlett to restart the section about his extramarital affair.
Bartlett said: “In September 2020 there was guidance given to stop us engaging in and having casual sex with people outside our household.”
ADVERTISEMENT
Matt Hancock appearing on the Diary of a CEO podcast. Credit: YouTube, Diary of a CEO
Hancock then interrupted him and said: “Do you think you could ask that question in a little bit more respectful way?”
He later added: “Can we just start this section again?
ADVERTISEMENT
“I don’t mind all of it except that opening bit about casual sex. I haven’t had casual sex with anybody, I fell in love with somebody.
“Let’s start this bit again and I’ll relax.”
Hancock said: “I resigned because I broke the social distancing guidelines. By then they weren’t actually rules, they weren’t the law, but that’s not the point.
ADVERTISEMENT
“The point is they were the guidelines that I’d been proposing, and that happened because I fell in love with somebody.”
The clip has been widely shared on social media today since the podcast was released.
Jim Bob edited the clip with the music from Our Tune, a long-standing feature/segment on British radio presented by broadcaster Simon Bates.
I don’t know who* added music to this but it’s brilliant. (*It was me. I’m brilliant) pic.twitter.com/GeLWP2IFVt
Another person wrote: “Oh Jesus god. I’ve just seen polo-necked Matt Hancock explaining that he broke the social distancing rules because he ‘fell in love’. And I don’t think I’ve ever seen such a nauseatingly self-indulgent clip. It could be worse than his snog video.”
Many people also had comments to make about Hancock’s outfit of a dark polo-neck top with skinny blue jeans – including Lorraine Kelly.
Lorraine said on her show this morning that he looked like a ‘pound shop Milk Tray man’ in reference to the Cadbury advert that aired between 1968 and 1984.
Transfers: Manchester United reportedly in the race for Rafael Leao as asking price is revealed
Danny Jones
In the latest transfer news coming out of Manchester, Man United are reportedly set to make the first move in an effort to sign Serie A star Rafael Leao after AC Milan are said to have ‘offered’ the wantaway winger to Premier League rivals Arsenal.
After being linked with MUFC on and off in the past, this could shape up to be a tasty tug of war if all rumours are to be believed.
But a recent interview by Leao may have pricked up ears over at Old Trafford and Carrington:
Do you think there are some hints being dropped here?…
Speaking to London-born and now Manchester-headquartered (interesting…) streetwear and jewellery brand Cernucci on their new podcast, the Portuguese international confessed to presenter Fred Buckley that he spent much of his childhood watching Man United, and still does to this day.
While he also admitted he likes Arsenal, adding even more fuel to the fire of the links with the Gunners, he also named Cristiano Ronaldo as his idol; either way, the ‘Rossoneri’ are believed to be asking for between £43-50 million for the former Sporting and Lille player.
A teammate of his with the national squad and having starred for major European sides, winning silverware – a Serie A title and Italian Super Cup, as well as a UEFA Nations League with Portugal – he’s evidently looking to try and emulate his fellow compatriots’ success moving forward.
Now 26 years old, he’s at a crucial juncture in his career, and despite being criticised for his work rate and efforts off the ball at times, not to mention blowing somewhat hot and cold in and around a fair few injury problems, the next big money move feels almost inevitable as he approaches his ‘prime’ years.
As you can see, many Milan fans have seemingly turned on him already after he made his plans to depart rather publicly, which has also seen him pop up on the radar of several other Champions League competitors this summer.
One such alternative suitor outside of English football is Galatasaray, with multiple Italian and Turkish outlets claiming that the club are the only team to be drawing up a ‘formal proposal’ thus far.
Journalist Matteo Moretto states that no official offer has been made as yet; he is also one of numerous sources who have revealed that Man United’s deal to sign Brazilian midfielder Ederson – also currently plying his trade in Italy – is now effectively ‘done’.
As for the mercurial forward, can you see Rafa Leao becoming a Red Devil?
Featured Images — Cernucci Podcast (screenshot via YouTube)/LHC88 (via Wikimedia Commons)
News
NHS rolls out new ‘life-extending’ ovarian cancer drug for first time in 20 years
Emily Sergeant
The NHS has approved a new ovarian cancer treatment for the first time in two decades.
From today, hundreds of women with ‘hard-to-treat’ ovarian cancer could benefit from a new life-extending drug on the NHS called mirvetuximab soravtansine, and it will be offered to patients living with whose disease has unfortunately stopped responding to standard chemotherapy treatments, providing them with new hope of extra time to live.
The rollout of the drug on the NHS follows a major global clinical trial involving eight NHS hospitals, which showed that the treatment delayed cancer progression and prolonged survival – with patients living 16.5 months on average compared to 12.8 months with chemotherapy.
One patient said the treatment enabled her to get on with life ‘rather than spending it in bed recovering from the side effects of chemotherapy’.
So, how does it work then?
The NHS has rolled out a new ‘life-extending’ ovarian cancer drug for the first time in 20 years / Credit: rawpixel
Well, the drug combines a ‘homing’ antibody with a cancer-killing medicine – often described by scientists as a ‘biological missile’ or ‘trojan horse’ therapy – and it works by attaching to ovarian cancer cells that have a protein called folate receptor alpha (FRα) on their surface, before releasing a cancer-killing molecule which destroys the cell from within.
The treatment is given intravenously, via a drip, over two to four hours, once every three weeks.
The drug may also have ‘more tolerable’ side effects than traditional chemotherapy, with the treatment aimed more precisely at cancer cells than chemotherapy.
The NHS estimates up to 400 patients in England each year could benefit.
“This represents the most significant breakthrough in NHS treatment for these hard-to-treat ovarian cancers in over two decades, commented Professor Ruth Plummer, who is the NHS’s national clinical lead for cancer drugs.
“We’re delighted it will now offer hundreds of women much-needed hope of precious extra time with their loved ones.
“It is part of a growing wave of more targeted cancer therapies which, by homing in on specific features of cancer cells, are helping us improve patients’ lives.”
Daisy Jackson -
1st March 2022 
